Test-retest Stability of MR-parameters. A Neuroimaging Pilot-study in

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05968976` - Multicentre RCT of Awake Versus Asleep Tractography Based DBS for ET	N/A
Completed	`NCT06183775` - Functional Magnetic Resonance Imaging Study on the Role of Awareness in Visual Perception in Healthy Adult Subjects.
Completed	`NCT04270903` - EPR (Electron Paramagnetic Resonance) as Method of Non-invasive Characterization of Melanin Content in Skins With Different Phototypes
Completed	`NCT05754905` - High-resolution CE-MRA of Children's Hip Joint

See also

Status

Clinical Trial

Phase

Recruiting

NCT05968976 - Multicentre RCT of Awake Versus Asleep Tractography Based DBS for ET

N/A

Completed

NCT06183775 - Functional Magnetic Resonance Imaging Study on the Role of Awareness in Visual Perception in Healthy Adult Subjects.

Completed

NCT04270903 - EPR (Electron Paramagnetic Resonance) as Method of Non-invasive Characterization of Melanin Content in Skins With Different Phototypes

Completed

NCT05754905 - High-resolution CE-MRA of Children's Hip Joint

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01239615
Study type	Observational
Source	Aarhus University Hospital
Contact
Status	Withdrawn
Phase	N/A
Start date	January 2011
Completion date	January 2012

Test-retest Stability of MR-parameters. A Neuroimaging Pilot-study in Healthy Volunteers

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms